lululemon athletica faces slowing sales growth, margin contraction, and weak forward guidance, justifying a continued bearish ...

FinVolution’s global growth, undervaluation, and low-risk Pakistan expansion offer major upside with solid fundamentals. See ...

NZD/USD extends its winning streak for the third trading day on Friday. The Kiwi pair stays below the 200-day Exponential ...

Ethena (ENA) ends the week on the back foot, falling to an intraday low of $0.6546 on Friday. The native token of the ...

Investing.com -- Bayer AG ’s menopause drug Lynkuet received backing from European regulators, moving closer to approval in the European Union.

For traders, the $114K–$116.5K zone is critical. Holding this support keeps Bitcoin’s higher-lows structure from early ...

Meta Platforms ( META -0.26%) is set to release its latest earnings report on Oct. 29. So, is the company's stock a buy heading into this report? Let's break it down.

Whether you're on the buy side or the sell side of a transition, business owners should consider these five points when ...

Pending the European Commission’s final decision, nipocalimab could be the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK ...